Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium aspartate is an ionic salt formed from potassium and L-aspartic acid. It functions primarily as a dietary supplement and electrolyte replenisher, crucial for correcting or preventing potassium deficiency, also known as hypokalemia. The compound dissociates in the gastrointestinal tract, releasing potassium ions that are absorbed into the bloodstream to restore normal cellular function, support nerve impulses, and maintain muscle contractions. The L-aspartate component acts as a carrier to facilitate potassium absorption into cells and also contributes to energy production through its role in the Krebs cycle and ammonia detoxification via the urea cycle. It is also investigated for its potential in managing hypertension and hyperammonemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Potassium aspartate.